These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Cancer chemotherapy of inoperable bronchial carcinomas (author's transl)]. Rieche K Z Erkr Atmungsorgane; 1975 Feb; 142(2):140-8. PubMed ID: 179223 [TBL] [Abstract][Full Text] [Related]
3. [Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)]. Dundalek E Prax Klin Pneumol; 1980 Dec; 34(12):719-23. PubMed ID: 7465532 [No Abstract] [Full Text] [Related]
4. [Chemotherapy in bronchogenic carcinoma (author's transl)]. Bruntsch U Rontgenblatter; 1977 Apr; 30(4):196-201. PubMed ID: 67629 [TBL] [Abstract][Full Text] [Related]
5. [Antineoplastic chemotherapy for bronchial carcinoma]. Tanneberger S Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017 [TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients. Samson MK; Baker LH; Fraile RJ; Izbicki RM; Vaitkevicius VK Cancer Treat Rep; 1977; 61(1):59-64. PubMed ID: 67895 [TBL] [Abstract][Full Text] [Related]
7. High-dose cyclophosphamide versus cyclophosphamide, methotrexate, 5-FU, and hydroxyurea (CMFH) in the treatment of stage III non-small cell bronchogenic carcinoma: a randomized trial. Pannuti F; Lelli G; Casadio M; Piana E; Di Marco AR Cancer Treat Rep; 1980; 64(10-11):1131-4. PubMed ID: 7459899 [TBL] [Abstract][Full Text] [Related]
8. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)]. Michlmayr G; Kratzer H; Denz H; Huber H Wien Klin Wochenschr; 1981 Mar; 93(6):205-7. PubMed ID: 7281697 [TBL] [Abstract][Full Text] [Related]
9. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma. Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331 [TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy of anaplastic carcinoma with adriamycin, vincristine, methotrexate and cyclophosphamide (author's transl)]. Chauvergne J; Durand M; Hoerni B; Brunet R; Bui BN Bull Cancer; 1980; 67(2):167-74. PubMed ID: 7448439 [TBL] [Abstract][Full Text] [Related]
11. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma]. Ryssel HJ; Hasler E; Sonntag RW; Cavalli F; Martin J; Tschopp L; Brunner KW Schweiz Med Wochenschr; 1977 Jul; 107(26):912-5. PubMed ID: 877537 [TBL] [Abstract][Full Text] [Related]
12. Relationship between myelosuppression and chemotherapeutic response in small cell bronchogenic carcinoma. Holoye PY Exp Hematol; 1985; 13 Suppl 16():72-9. PubMed ID: 2985416 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapy in bronchogenic carcinoma. Ojala A; Nikkanen VN; Palojoki A; Paloheimo S Ann Clin Res; 1977 Feb; 9(1):12-4. PubMed ID: 329741 [TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors in the chemotherapy of bronchial cancers]. Alberto P Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755 [No Abstract] [Full Text] [Related]
15. Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell. Livingston RB Cancer Treat Rev; 1977 Sep; 4(3):153-65. PubMed ID: 73419 [No Abstract] [Full Text] [Related]
16. [Integrated chemotherapy and radiotherapy of inoperable bronchial carcinoma: preliminary results in 50 cases (author's transl)]. Seeber S; Schmidt CG; Holfeld H; Scherer E Dtsch Med Wochenschr; 1977 Feb; 102(5):147-52. PubMed ID: 832600 [TBL] [Abstract][Full Text] [Related]